Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Primary mitochondrial disorders (PMDs) are severe, often lethal, multisystem metabolic diseases caused by oxidative phosphorylation (OXPHOS) defects.
• Nutritional interventions are commonly used in PMD management, but their mechanistic basis, efficacy, and safety lack robust evidence.
• Preclinical cellular and animal models are vital for studying PMD mechanisms and evaluating therapeutic strategies.

Purpose of the Study:

• To review the mechanistic rationale and experimental evidence for nutritional interventions in PMDs.
• To identify knowledge gaps and challenges in conducting randomized controlled trials for PMD nutritional therapies.
• To evaluate the utility of preclinical models in understanding PMD pathophysiology and assessing interventions.

Main Methods:

• Literature review of mechanistic rationale and experimental evidence for nutritional interventions (micronutrients, metabolic agents, signaling modifiers, dietary regulation).
• Assessment of cellular and animal models that mimic specific PMDs.
• Evaluation of model systems for their potential in elucidating disease mechanisms and therapeutic outcomes.

Main Results:

• Limited mechanistic understanding and evidence for the efficacy and safety of current nutritional interventions in PMDs.
• Preclinical models show promise for investigating PMD mechanisms and testing therapeutic strategies.
• Significant knowledge gaps and impediments exist for advancing to clinical trials.

Conclusions:

• Further research is needed to establish the efficacy and safety of nutritional interventions for primary mitochondrial disorders.
• Preclinical models are essential tools for advancing the understanding and treatment of these complex metabolic diseases.
• Bridging the gap between preclinical findings and clinical application is critical for improving patient outcomes.